Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression (2006)
- Authors:
- Autor USP: MENDES, JOAO GUSTAVO PESSINI AMARANTE - ICB
- Unidade: ICB
- Assunto: IMUNOLOGIA
- Language: Inglês
- Abstract: Introduction and Aims: Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by clonal expansion of neoplastic hematopoietic stem cell, the neogene Bcr-Abl is a hallmark of CML. PRAME (Preferentially Expressed Antigen in Melanoma) was first described as an antigen in human melanoma, which triggers autologous cytotoxic T cell-mediated immune responses. The correlation between the bcr-abl and prame expression has previously been suggested but this association is still unclear. Our goals were to determine the possible correlation among prame expression, Bcr-Abl levels, CML progression, and response to imatinib (Gleevec ® ). Methods and Results: prame expression was evaluated in many cell lines, such as HL-60, HL-60.BcrAbl, HeLa, HeLa.BcrAbl, Jurkat, Jurkat.BcrAbl, K562, KBM5, KBM7, KCL22, LAMA-84, SKW.64, SKW.BcrAbl, THP1, and THP1.BcrAbl (with or without imatinib) and 22 CML patients in different phases and in cytogenetic remission post-imatinib by real-time RT-PCR. We found a correlation between bcr-abl and prame in HL-60 X HL-60.BcrAbl in which prame expression was 48-times higher in HL-60.Bcr-Abl.Moreover, we did not detect any association between imatinib treatment and prame expression, which support that this is independent of the Bcr-Abl tyrosine kinase activity. On the other hand, a higher prame expression was related to disease progression. This gene expression was 8-times and 29-times higher inaccelerated and blastic phase than in chronic phase, respectively. Prame levels were lower in post-imatinib cytogenetic remission patients when comparing to refractory patients. Conclusion: Tyrosine kinase-independent prame expression and its correlation with disease progression suggest that PRAME might be involved in Bcr-Abl mediated leukemogenesis. Besides, prame was recently described as a dominant repressor of retinoic acid receptor (RAR). Signaling through RAR induce growth arrest, differentiation, and apoptosis in many cell types. Taken these data together, new treatments can be developed, aiming to inhibit the function or expression of prame, for the most delayed phase, in imatinib-refractory patients.
- Imprenta:
- Source:
- Título do periódico: Abstracts
- Conference titles: Meeting of the Brazilian Society for Immunology
-
ABNT
CARVALHO, D D et al. Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression. 2006, Anais.. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2006. . Acesso em: 21 maio 2024. -
APA
Carvalho, D. D., Proto-Siqueira, R., Leroy, J. M. G., Pereira, W. O., Bueno-da-Silva, A. E., Jacysyn, J. F., et al. (2006). Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression. In Abstracts. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo. -
NLM
Carvalho DD, Proto-Siqueira R, Leroy JMG, Pereira WO, Bueno-da-Silva AE, Jacysyn JF, Zanichelli MA, Camanho D, Collassanti MD, Hamerschlak N, Zago MA, Castro FA, Amarante-Mendes JGP. Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression. Abstracts. 2006 ;[citado 2024 maio 21 ] -
Vancouver
Carvalho DD, Proto-Siqueira R, Leroy JMG, Pereira WO, Bueno-da-Silva AE, Jacysyn JF, Zanichelli MA, Camanho D, Collassanti MD, Hamerschlak N, Zago MA, Castro FA, Amarante-Mendes JGP. Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression. Abstracts. 2006 ;[citado 2024 maio 21 ] - Interação entre timócitos e um clone de células do estroma tímico
- The regulation of apoptotic cell death
- Modification of phosphatidylinositol 3-kinase SH2 domain binding properties by Abl- or Lck-mediated tyrosine phosphorylation at Tyr-688
- Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3
- Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity
- MHC class I positive and negative RMA cells induce different pathological features in C57BL/6 mice
- Endostatin-Bax: a novel fusion protein with enhanced antiangiogênic activity
- Apoptosis induced by manganese in hematopoietic cell lines
- Apoptosis of macrophages during pulmonary Mycobacterium bovis infection: correlation with intracellular bacillary load and cytokine levels
- Differential antitumor effects of igg and igm monoclonal antibodies and their synthetic complementarity-determining regions directed to new targets of b16f10-nex2 melanoma cells
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
